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Introduction
Good sleep safeguards physical health and quality of life, and contributes to cognitive and emotional functions. Prolonged sleep deprivation (SD) increases the risk of mood disorders (Alvaro, Roberts, Harris, & Bruni, 2017) and impairs regulation of emotions (Goldstein & Walker, 2014) . Our previous studies revealed that chronic SD induces depressive-like behaviours via stimulating an astroglial neuroinflammatory response.
This response is linked to activation of P2X7 purinoceptors associated with the activation of nucleotide-binding domain and leucine-rich repeat protein-3 (NLRP3) inflammasome.
We also found that the anti-depressant fluoxetine suppresses the activation of NLRP3 inflammasome caused by SD via astroglial 5-HT2B receptors . However, the details P2X7R and 5-HT2BR interactions are still unknown, especially in the context of chronic SD.
Dynamic changes of brain extracellular ATP during sleep-wake cycle have not been studied extensively. Increased ATP release from neurones during the period of wakefulness was nonetheless suggested to activate P2X7R in neural cells (Chennaoui et al., 2017) . Functional P2X7Rs are distributed in cortex, hippocampus and retina, and P2X7R interferes with the sleep rhythms directly or indirectly through the release of cytokines and neurotransmitters (Illes, Verkhratsky, Burnstock, & Franke, 2012) .
Expression of P2X7Rs was up-regulated in people subjected to chronic SD; and these changes in expression were linked to the cycling in bipolar disorder (Backlund et al., 2012) .
The 5-HT2BRs are related to the major depressive disorder (MDD); these receptors expressed in astrocytes are targets for serotonin-specific re-uptake inhibitors (SSRIs) (Li, 5 Zhang, Li, Hertz, & Peng, 2009; Li, Zhang, Zhang, Hertz, & Peng, 2011; Li et al., 2008; Li et al., 2018; Peng, Gu, Li, & Hertz, 2014; Peng, Song, Li, & Verkhratsky, 2018) .
Down-regulation of 5-HT2BRs leads to a loss of sleep homeostasis in Drosophila (Qian et al., 2017) . We found that leptin enhances the anti-depressive potential of fluoxetine in the context of SD-induced depression by stimulating 5-HT2BR in astrocytes with consequent increase in the phosphorylation of ERK1/2 (Li, Zhang, Li, Hertz, & Peng, 2010) . We also found that 5-HT2BRs regulate expression of Ca 2+ -dependent phospholipase A2 (cPLA2) via transactivation of epidermal growth factor receptor (EGFR) . In spinal cord astrocytes, the phosphorylation of cPLA2 induced by ATP induces the rapid release of arachidonic acid (AA) and prostaglandin E2 (PGE2) (Xia & Zhu, 2011) .
Ionotropic P2X7Rs promote NLRP3 inflammasome assembly and trigger ATP-induced release of mature IL-1 and IL-18 in astrocytes . Activation of P2X7R is linked to NLRP3 inflammasome and induction of depressive-like behaviours induced by chronic stress (Yue et al., 2017) . Furthermore, P2X7Rs suppress phosphorylation of AKT and ERK induced by BzATP in microglia (Kim, Ko, Hyun, Min, & Kang, 2018) . We demonstrated that SD could decrease the phosphorylation of AKT, but not the phosphorylation of ERK , while activation of AKT can phosphorylate the Forkhead transcriptional factor FoxO3a on Ser253 site; the FoxO3a is an attractive candidate for regulating stress responses (Polter et al., 2009) .
In this study, we dissect how SD-induced activation of P2X7Rs regulates expression of 5-HT2BR and the production of arachidonic acid (AA) and prostaglandin E2 (PGE2) to reveal the possible mechanism linking chronic SD with mood disorders including the MDD. 6 2. Materials and Methods
Animals
As in our previous studies Xia, Yang, Sun, Qi, & Li, 2017) Chemicals for the preparation of cell sorting medium were obtained from Gibco Life Technology Invitrogen (USA).
Sleep Deprivation (SD)
As described previously (Franken, Dijk, Tobler, & Borbely, 1991) , the SD was maintained by "gentle handling" according to the standard protocols, gently touching the mouse with a brush to keep it awake in every cage. SD was operated for 6 hours, which began at 7 a.m. and ended at 1 p.m. During SD, the mice continually were offered food and water ad libitum. Animals in the sham group were preserved undisturbed in a separate room with the same light/dark rhythm as SD group. The mice were treated with sham or SD stimulation for 3 or 4 weeks.
Tissue Collection and Measurement of ATP-Content
Tissues were collected as described before (Dworak, McCarley, Kim, Kalinchuk, & Basheer, 2010) . Mice were killed by decapitation. Brain slices (2 mm thick) were carefully placed on dry ice containing covered Petri-dish for the rapid freezing and the ensuing dissection, frontal cortex region was selected. Extreme care was observed to complete this process rapidly; all the tissue samples were collected at 10 a.m. during the light period at the end of every week. The selected regions were held frozen on dry ice and stored at −80° C until used for the left measurements.
ATP levels were assessed with luciferin-luciferase based assay (Lundin & Thore, 1975; McElroy & DeLuca, 1983 ) using a commercial ATP assay system with bioluminescence detection kit (Enliten, Promega). ATP was measured according to the 8 manufacturer's protocol. In brief, weighed tissue samples were homogenised in 5% trichloroacetic acid (TCA) and centrifuged at 5000 rpm in cold for 5 min, the supernatant was transferred to a fresh tube. Samples were neutralised with Tris acetate buffer, the luciferase reagent was used immediately before measurement in the luminometer. The measured concentration was normalised to "0 week" point of sham group.
Cells Dissociation and Fluorescence-activated Cell Sorting (FACS)
B6.Cg-Tg(Thy1-YFP)HJrs/J and FVB/N-Tg(GFAP-GFP)14Mes/J mice were separately used for isolating neurones and astrocytes. A single-cell suspension from the cortex and hippocampus was prepared as previously described (Xia et al., 2017) . In brief, tissue from 3 mice was pooled for one sample. Wavelengths of 488 nm and 530/30 nm were used for YFP or GFP excitation and emission, respectively. YFP + or GFP + cells were sorted and collected. As this method, the purity of neurones or astrocytes sorted has been identified in our previous reports (Fu, Li, Hertz, & Peng, 2012) by checking mRNA level of cell specific markers of astrocytes, neurons and oligodendrocytes.
Primary Culture of Astrocytes
As described previously (Li et al., 2011; Li et al., 2008; Xia et al., 2017) , astrocytes isolated from the cerebral hemispheres of newborn C57BL/6 mice were cultured in Dulbecco's modified Eagle's medium (DMEM) with 7.5 mM glucose. From the third week, dibutyryl cyclic AMP (dBcAMP) was added to the medium.
Immunohistochemistry
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The brain tissue was fixed and immersed in 4% paraformaldehyde (PFA) and cut in 100 µm slices. Immunohistochemistry was performed as previously described (Li et al., 2016; Xia et al., 2017) . In brief, the following primary antibodies were used: mouse anti-5-HT2BR (1:150), mouse anti-P2X7 (1:150), chicken anti-NeuN (1:250), rabbit anti-Glt1
(1:200), rabbit anti-GFAP (1:250). The slices were incubated with Alexa Fluorconjugated secondary antibodies for 2 hours at room temperature (1:250). DAPI (1:2000) was stained to identify cell nuclei. Immunofluorescence was imaged using a confocal scanning microscope (DMi8, Leica, Germany). The background intensity of each image was calculated in cell-free parenchyma in the same field of view and subtracted from the total immunofluorescence intensity. The intensity of 5-HT2BR immunofluorescence from each group was normalised to the intensity of the sham group.
Western Blotting
As described previously (Li et al., 2016; Li et al., 2011) , the sections were blocked with powdered skim milk and incubated for 2 h with the primary antibodies at room temperature. After washing three times, specific binding was detected with horseradish peroxidase-conjugated secondary antibodies. Staining was visualised with ECL detection reagents, and images were acquired with an electrophoresis gel imaging analysis system.
Band density was measured in Windows AlphaEase FC 32-bit software.
Real-time PCR (RT-PCR)
As described previously (Xia et al., 2017) , total RNA was reverse transcribed, and PCR amplification was performed with a Thermo-cycler. The RNA quantities were normalised by glyceraldehyde 3-phosphate dehydrogenase (GAPDH) before calculating the relative expression of 5-HT2BR. Values were first calculated as the ratio of the relative expression of 5-HT2BR and GAPDH, then the values were normalised by sham group.
Over-expression of FoxO3a by Using Adenoviral Vectors
As described previously (Ren et al., 2018; Xia & Zhu, 2013) , replication-defective adenoviral vectors expressing dominant wild type FoxO3a were designed and purchased from TaKaRa Biotechnology (Dalian, China). The wild-type FoxO3a had a hemagglutinin tag at the N-terminus and expressed green fluorescent protein (GFP).
Astrocytes were infected with recombinant adenovirus in DMEM medium for 8 h, after which the medium was replaced by fresh complete culture medium including 10% foetal bovine serum. The infection efficiency was close to 80 %, as determined by the GFP expression.
2.11 Assessment of Arachidonic Acid (AA) Mobilisation
As described previously (Xia & Zhu, 2011 , the release of 3 H from astrocytes prelabelled with [ 3 H]AA was used to monitor the response to serotonin. Confluent cultures were changed by quiescent medium for 24 h before they were labelled for 4 h with 1 μCi/ml [ 3 H] arachidonic acid (PerkinElmer Life Sciences). Washing cells once with PBS containing 0.1% free fatty acid albumin and twice with PBS alone. Astrocytes were then incubated at 37 °C in fresh Ham's F-12 medium supplemented with 0.1% free fatty acid albumin plus serotonin or PBS. The astrocytes were washed with 5% Triton and scraped off. The radioactivity levels of astrocytes and medium were quantified by scintillation 11 counting. The results were normalised and expressed as a percentage of the mean of the basal release.
PGE2 Assays
As described previously (Xia & Zhu, 2011 , PGE2 levels were monitored by using enzyme immunoassay kit (Cayman Chemical, Ann Arbor, MI). The assay was operated according to the manufacturer's protocols. PGE2 production was evaluated in duplicate, and concentrations were calculated from a standard curve of PGE2 standards. The sensitivity of the assay allowed detection of up to 15 pg/ml. When necessary, the samples were diluted in the assay buffer.
Tail Suspension Test (TST)
TST is a behavioural despair-based test. The mouse was suspended by its tail around 2 cm from the tip as our previous description Xia et al., 2017) , behaviour was recorded for 6 min. The duration of immobility was measured by an observer blinded to the treatment groups.
Forced Swimming Test (FST)
FST is also a behavioural despair-based test. In brief, each mouse was trained to swim 15 min before the formal measurement. Then the trained mouse was put into a glass cylinder that contained 30 cm deep water (25 ± 1•C) for 6 min. The time of immobility was recorded during the last 4 min period which followed 2 min of habituation Xia et al., 2017) . 12 2.15 Sucrose Preference Test
As previously described Xia et al., 2017) , the sucrose preference test is a reward-based test and a measure of anhedonia. Briefly, after 12 hours of food and water deprivation, the mice were provided with two bottles which were pre-weighed, including one bottle was filled with 2.5% sucrose solution and a second bottle contained water, for 2 h. The percentage preference was calculated according to the following formula: % preference = [sucrose intake/(sucrose + water intake)] x 100%.
Statistical Analysis
All measurements were performed by an investigator blinded to the experimental conditions. Differences between multiple groups were evaluated by analysis of variance (ANOVA) followed by Fisher's least significant difference (LSD) or a Tukey-Kramer post hoc multiple comparison test for unequal replications using GraphPad Prism 5 software (GraphPad Software Inc., La Jolla, CA). All statistical data are expressed as the mean ± SEM; the level of significance was set at p < 0.05.
Results
SD Specifically Down-regulates 5-HT2BR expression in Astrocytes
After the treatment with SD for 3 weeks, the fluorescence intensity of 5-HT2BR immunoreactivity was significantly decreased by 68 ± 7.1% (n = 6) in astrocytes when compared with a sham group; there was no obvious difference in 5-HT2BRs expression in neurones between sham and SD groups (Fig. 1A, B ). We further measured expression of 13 5-HT2BR in neurones and astrocytes FACS sorted from Thy1-YFP and GFAP-GFP mice treated with SD. As shown in Fig. 1C , the mRNA level of 5-HT2BR was significantly suppressed by 71 ± 5.2% (n = 6) in astrocytes, however, SD marginally and nonsignificantly affected expression of 5-HT2BR in neurones.
SD Induced Downregulation of 5-HT2BR is Mediated by P2X7R
The SD induced down-regulation of 5-HT2BRs was completely eliminated in astrocytes from P2X7R-KO mice (expression of P2X7R in P2X7R-KO mice was significantly suppressed, as shown in Fig 2A) . The fluorescence intensity of 5-HT2BR immunoreactivity in astrocytes was 92 ± 15.2% of control group, whereas it was 105 ± 10.8% of control group in neurones (Fig. 2B, C) .
The SD-related changes in protein expression of 5-HT2BR quantified by western blotting, were similarly absent in P2X7R-KO mice (Fig. 2D ). The treatment with SD significantly reduced the expression of 5-HT2BR to 32% of control group in wild type mice, whereas the level of 5-HT2BR in SD group was 89 ± 4.8% of control group in P2X7R-KO mice, and there was no obvious difference in the expression of 5-HT2BR in astrocytes from WT control and from P2X7R-KO mice (Fig. 2E) .
The mRNA level of 5-HT2BR measured by RT-PCR reflected protein expression. As compared with control, mRNA expression of 5-HT2BR was significantly down-regulated by 79 ± 3.9% in SD group of the wild type mice (Fig. 2F) . However, the treatment with SD decreased expression of 5-HT2BR mRNA only by 6 ± 2.5% of control in P2X7R-KO mice (Fig. 2F ).
14 Meanwhile, we measured the effect of 4 weeks of SD on ATP levels in the frontal cortex. As shown in Fig. 2G , treatment with SD resulted in gradual increase of the level of ATP. As compared with the initial point (0 week) and control groups SD significantly increased ATP by 52 ± 17.1% at 1 week, by 107 ± 20.7% at 2 weeks, by 143 ± 22.2% at 3 weeks, by 151 ± 25.4% at 4 weeks (n = 6); there were no statistical difference in the level of ATP from 2 to 4 weeks. (Fig. 2G ). Moreover, there was no significant fluctuation of ATP level from 0 to 4 weeks in control group (Fig. 2G) .
The Involvement of AKT and FoxO3a in Regulation of 5-HT2BR by P2X7R in vivo and in vitro
In wild type mice treated with SD, the phosphorylation of AKT (Ser473) was significantly reduced by 58 ± 3.3% (n = 6) of control group (Fig. 3A) , the phosphorylation of FoxO3a (Ser253) was decreased by 61 ± 5.4% (n = 6) as compared with controls ( Fig. 3B ). To the contrary in P2X7R-KO mice treated with SD, the phosphorylation of AKT was somewhat increased to 116 ± 16.4% (n = 6) of control group (Fig. 3A) , whereas the level of p-FoxO3a was 123 ± 12.3% (n = 6) of control group (Fig. 3B) ; there were no significant difference between control and SD groups.
We used SD-treated Thy1-YFP or GFAP-GFP transgenic mice to measure the levels of p-AKT and p-FoxO3a in the FACS sorted neurones or astrocytes. As shown in Fig. 3C , the treatment with SD selectively decreased the phosphorylation of AKT in astrocytes by 57 ± 4.7% (n = 6) of control group, whereas no obvious difference existed between control and SD groups in neurones. Similarly, the SD suppressed the phosphorylation of FoxO3a by 69 ± 5.2% (n = 6) in astrocytes as compared with controls, while no changes in neurones were observed (Fig. 3D ).
In primary cultured astrocytes, we used P2X7R agonist (BzATP) to simulate the effects of ATP on P2X7R induced by SD. For probing the regulation mechanism of P2X7R on the expression of 5-HT2BR in the primary cultured astrocytes, mRNA of P2X7R was RNA interfered with siRNA duplex. This manipulation decreased the level of P2X7R by 88 ± 3.4% of control group (Fig. 4A) . For identifying the effect of transcription factor FoxO3a on the expression of 5-HT2BR, we over-expressed the FoxO3a in primary cultured astrocytes, as shown in Fig. 4B .
Administration of BzATP reduced the phosphorylation of AKT by 66 ± 4.3% of PBS control group in astrocytes (Fig. 4C) . In contrast, after treatment with siRNA interfering, the effect of BzATP on the phosphorylation of AKT was abolished, as there was no significant difference between PBS and BzATP groups (Fig. 4C ). Phosphorylation of FoxO3a was decreased by 52 ± 4.1% (n = 6) in BzATP group, as compared with PBS control (Fig. 4D) . After 3 days of P2X7R siRNA treatment, the phosphorylation of FoxO3a treated with BzATP was recovered to 94 ± 7.7% of PBS group (Fig. 4D ). In astrocytes, BzATP reduced the expression of 5-HT2BR by 69 ± 3.2% of PBS control group (Fig. 4E ). This effect was eliminated after siRNA treatment: in the presence of BzATP the level of 5-HT2BR decreased, insignificantly, to 91 ± 7.3% (n = 6) of PBS group (Fig. 4E) . After over-expressing FoxO3a, the basic level of 5-HT2BR was elevated by 62 ± 4.7% as compared with PBS group without over-expression, but BzATP did not change the expression of 5-HT2BR (Fig. 4E) . 16 3.4 The Effects of P2X7R on the Phosphorylation of STAT3 and cPLA2 are Related to 5-HT2BR in vivo and in vitro
Exposure of mice to SD decreased the phosphorylation of STAT3 by 66 ± 5.4% of control, however, this effect was abolished in P2X7R-KO mice, the level of p-AKT in SD group was 97 ± 8.9% control (Fig. 5A) . In contrast, SD had an opposite effect on the activation of cPLA2. As shown in Fig. 5B , the phosphorylation of cPLA2 in animals exposed to SD increased by 67 ± 8.7% (n = 6) as compared with controls. This effect was absent in P2X7R-KO mice in which SD did not stimulate the activation of cPLA2 (Fig.   5B ).
In experiments in vitro, we employed 5-HT2BR agonist BW723C86 (BW) to stimulate 5-HT2BR. In cultured astrocytes, BW induced the phosphorylation of STAT3 by 73 ± 10.7% (n = 6) of control group; the 5-HT2BR specific antagonist SB204741 totally suppressed the phosphorylation of STAT3 stimulated by BW (Fig. 5C ). Treatment with BW decreased the level of p-cPLA2 by 57 ± 3.9% (n = 6) of control group, while the irreversible STAT3 activation inhibitor Stattic elevated the phosphorylation of cPLA2 to 96 ± 8.7% (n = 6) of control group, there was no difference between control and stattic groups (Fig. 5D ).
The BW decreased levels of AA and PGE2 by 31 ± 7.1% and 57 ± 3.3% respectively (n = 6) when compared with the control group, (Fig. 5E and 5F ). Exposure to Stattic increased the release of AA and PGE2 reduced by BW to 105 ± 12.2% and 116 ± 12.7% of control ( Fig. 5E and 5F ).
Effects of P2X7R on the Depressive-Like Behaviours Induced by SD
We monitored depressive-like behaviours in P2X7R-KO mice, as shown in Fig. 6 . There was no obvious difference in body weight between the control and SD groups of wild type and P2X7R-KO mice (Fig. 6A) . In sucrose preference test, treatment with SD decreased the uptake percentage of sucrose water by 47 ± 5.3% (n = 6) as compared with control group in WT mice (Fig. 6B) . The anhedonia induced by SD was abolished in P2X7R-KO mice, the uptake of sucrose water was 89 ± 4.7% of control (Fig. 6B ). In the tail suspension test (TST), the immobility time of SD group was prolonged to 155 ± 15.1% of control, while this time was cut down to 107 ± 11.2% control in P2X7R-KO mice (Fig. 6C) . Similarly, the immobility time in forced swimming test (FST) was increased by 106 ± 11.7% of control group, the time was increased only to 113 ± 9.5% of sham group in P2X7R-KO mice (Fig. 6D ).
Discussion
Our study shows that the chronic SD gradually increases the release of ATP that subsequently stimulates P2X7Rs which decreases the expression of 5-HT2BR specifically in astrocytes. Such an effect was not observed in neurones. Stimulation of P2X7Rs triggered by SD suppressed the expression of 5-HT2BR through inhibiting the phosphorylation of AKT (Ser473) and FoxO3a (Ser253) in astrocytes. The dephosphorylated FoxO3a translocates into nucleus Polter et al., 2009) , increased FoxO3a in nucleus down-regulates the expression of 5-HT2BR in astrocytes.
The downregulation of 5-HT2BR induced by SD caused the decrease in the activation of STAT3 which inhibits activation of cPLA2. As a result, chronic SD indirectly stimulated the phosphorylation of cPLA2 via down-regulating the expression of 5-HT2BR in 18 astrocytes. This increased activation of cPLA2 stimulates the release of AA and PGE2, which may be linked to the depressive-like behaviours (Fig. 7) .
Mechanisms of sleep are complex and sleep impairments have numerous negative impacts. The sleep regulatory signal triggered by extracellular ATP activates glial P2X7Rs, which stimulates the release of pro-inflammatory cytokines, such as TNF- and IL-1 (Krueger, Huang, Rector, & Buysse, 2013) . Although there are some reports about the pattern of ATP dynamics in sleep or SD (Chennaoui et al., 2017; Dworak et al., 2010) , fluctuation of ATP in long-term SD remained unexplored. Here we demonstrate the gradual increase in ATP levels in frontal cortex in the course of chronic SD. Elevated expression of P2X7R in monocytes of healthy subjects was reported to be related with a stress response to SD (Backlund et al., 2012) . In addition, we found that the activation of NLRP3 inflammasomes induced by long-term SD was abolished in P2X7R-KO mice, the effects of long-term SD on the neuronal apoptosis was also eliminated through inhibiting the inflammasomes activation .
According to our previous reports, astroglial 5-HT2BRs are the key target of selective serotonin reuptake inhibitors (SSRIs). In particular fluoxetine directly stimulates astroglial 5-HT2BR thus mediating anti-depressant action Li et al., 2008; Peng et al., 2014; Peng et al., 2018) . Expression of 5-HT2BR elevated by leptin enhances positive effects of fluoxetine on the depressive-like behaviours induced by chronic SD . In the present study, long-term SD selectively blocked the expression of 5-HT2BR by activation of P2X7R in astrocytes ( Fig. 1 and Fig. 2) . Activation of P2X7Rs induced by SD decreased the phosphorylation of AKT selectively in astrocytes, but did not change the level of p-AKT in neurones (Fig. 3A and 3C) . Likewise, BzATP induced the dephosphorylation of AKT in primary cultured astrocytes (Fig. 4C) , similar effects of BzATP on the dephosphorylation of AKT was also reported in microglia (He, Taylor, Fourgeaud, & Bhattacharya, 2017) . At the same time BzATP did not change the activation of AKT in granule neurones (Ortega, Pérez-Sen, Delicado, & Miras-Portugal, 2009 ). Activated AKT phosphorylates FoxO3a at Ser253 in cytoplasm Polter et al., 2009) . In contrast, dephosphorylation of FOXO3a causes its translocation from the cytoplasm into the nucleus, which triggers downstream gene expression Polter et al., 2009) . We demonstrate that stimulation of astrocytic P2X7Rs suppressed the phosphorylation of FoxO3a in vivo and in vitro (Fig. 3B, D and 4D) , which promoted the translocation of FoxO3a to the nucleus and inhibited the expression of 5-HT2BR. Over-expression of FoxO3a in the nucleus decreased the level of 5-HT2BRs ( Fig. 4E) , while the FoxO3a-KO mice present obvious anti-depressive-like behaviours (Polter et al., 2009) .
We previously reported that chronic SD decreases the phosphorylation of STAT3 in astrocytes . In this study, we show that the decrease of p-STAT3 induced by SD was caused by the reduced expression of 5-HT2BR, because the activation of 5-HT2BR by an agonist (BW) increased the phosphorylation of STAT3 in astrocytes (Fig.   5C ). In spinal cord astrocytes, treatment with ATP increases the activation of cPLA2, however, the pre-treatment with leptin eliminates the phosphorylation of cPLA2 induced by ATP via increasing the level of p-STAT3 and caveolin-1, which in turn reduces the release of AA and PGE2 (Li et al., 2016) . cPLA2 selectively acts on AA containing acyl chains in vitro (Sundler, Winstedt, & Wijkander, 1994) and cPLA2 is a crucial enzyme in AA-derived eicosanoid production (Dennis, Cao, Hsu, Magrioti, & Kokotos, 2011). 20 PGE2 is metabolised from AA by the cyclooxygenase (COX) and it is an important regulator of chronic inflammation (Kalinski, 2012) . The long-term treatment with SD induced the phosphorylation of cPLA2 and increased the release of AA and PGE2 via regulating 5-HT2BR in astrocytes (Fig. 5) .
Both cPLA2 and COX-2 have been reported to associate with major depressive disorder (Gałecki, Florkowski, Bieńkiewicz, & Szemraj, 2010; Pae et al., 2004) , the increased level of PGE2 is measured in depression, and COX-2 inhibitors are suggested to be used as antidepressants (Mueller, 2010) . In this study, chronic SD induced the activation of cPLA2 which could trigger production of AA and PGE2 via P2X7R (Fig. 5) ,
while the depressive-like behaviours induced by long-term SD were abolished in P2X7R-KO mice (Fig. 6) .
In summary, our study revealed the mechanism underlying depressive-like behaviours induced by chronic SD, and discovered, for the first time, that decreased expression of 5-HT2BR induced by SD was mediated through P2X7Rs. Down-regulated 5-HT2BR dephosphorylated STAT3 thus relieving the inhibitory effect of STAT3 on the activation of cPLA2. Our results propose the selective agonist of 5-HT2BR or the reagent which could up-regulate the expression of 5-HT2BR may be considered as the therapeutic agents for preventing depression triggered by sleep disorders. 
